Chronic nightly dosing of lasmiditan for migraine prevention

Chronic nightly dosing of lasmiditan for migraine prevention

The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CONLEY, Robert Russell, JOHNSON, Kirk Willis, DAVAR, Gudarz
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CONLEY, Robert Russell
JOHNSON, Kirk Willis
DAVAR, Gudarz
description The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2019336667BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2019336667BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2019336667BB23</originalsourceid><addsrcrecordid>eNrjZLBxzijKz8tMVsjLTM8oyalUSMkvzsxLV8hPU8hJLM7NTMksScxTSMsvUsjNTC9KzMxLVSgoSi1LzSvJzM_jYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoaWxsZmZmbmTk5GxkQqAwAr0TGU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chronic nightly dosing of lasmiditan for migraine prevention</title><source>esp@cenet</source><creator>CONLEY, Robert Russell ; JOHNSON, Kirk Willis ; DAVAR, Gudarz</creator><creatorcontrib>CONLEY, Robert Russell ; JOHNSON, Kirk Willis ; DAVAR, Gudarz</creatorcontrib><description>The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220929&amp;DB=EPODOC&amp;CC=AU&amp;NR=2019336667B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220929&amp;DB=EPODOC&amp;CC=AU&amp;NR=2019336667B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CONLEY, Robert Russell</creatorcontrib><creatorcontrib>JOHNSON, Kirk Willis</creatorcontrib><creatorcontrib>DAVAR, Gudarz</creatorcontrib><title>Chronic nightly dosing of lasmiditan for migraine prevention</title><description>The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBxzijKz8tMVsjLTM8oyalUSMkvzsxLV8hPU8hJLM7NTMksScxTSMsvUsjNTC9KzMxLVSgoSi1LzSvJzM_jYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoaWxsZmZmbmTk5GxkQqAwAr0TGU</recordid><startdate>20220929</startdate><enddate>20220929</enddate><creator>CONLEY, Robert Russell</creator><creator>JOHNSON, Kirk Willis</creator><creator>DAVAR, Gudarz</creator><scope>EVB</scope></search><sort><creationdate>20220929</creationdate><title>Chronic nightly dosing of lasmiditan for migraine prevention</title><author>CONLEY, Robert Russell ; JOHNSON, Kirk Willis ; DAVAR, Gudarz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2019336667BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CONLEY, Robert Russell</creatorcontrib><creatorcontrib>JOHNSON, Kirk Willis</creatorcontrib><creatorcontrib>DAVAR, Gudarz</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CONLEY, Robert Russell</au><au>JOHNSON, Kirk Willis</au><au>DAVAR, Gudarz</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chronic nightly dosing of lasmiditan for migraine prevention</title><date>2022-09-29</date><risdate>2022</risdate><abstract>The present invention relates to chronic nightly use of lasmiditan for the prevention of migraine, particularly therapy resistant migraine which is defined herein as migraine refractory to two or more prior monotherapy and/or dual therapy treatment or prevention regimens.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2019336667BB2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Chronic nightly dosing of lasmiditan for migraine prevention
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T18%3A33%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CONLEY,%20Robert%20Russell&rft.date=2022-09-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2019336667BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true